Cognition Therapeutics (CGTX) Tax Rate (2022)

Cognition Therapeutics (CGTX) posted quarterly Tax Rate of 2.13% for Q2 2022, up 163.18% quarter-over-quarter from 3.37% in Q1 2022.

Cognition Therapeutics (CGTX) Tax Rate (2022) Analysis & Trends

Cognition Therapeutics (CGTX) has reported Tax Rate for 1 consecutive years, with 2.13% the latest figure, recorded in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Cognition Therapeutics	90.18 Mn	90.18 Mn	-	-

Download Data